Home Newsfeeds Credit Suisse Downgrades Trex Co to Underperform

Credit Suisse Downgrades Trex Co to Underperform

Credit Suisse analyst Daniel Oppenheim downgrades Trex Co (NYSE:TREX) from Neutral to Underperform.

byBenzinga Newsdesk

October 14, 2022

1 minute read

Credit Suisse analyst Daniel Oppenheim downgrades Trex Co (NYSE:TREX) from Neutral to Underperform.

FDA
News

Amneal Announces Submission of New Drug Application to the U.S. FDA for IPX203 for the Treatment of Parkinson’s Disease

By Michael Horton

August 31, 4:36 PM

- IPX203 is a novel, extended-release oral formulation of carbidopa and levodopa that if approved, would offer patients more "Good On" time with fewer doses Amneal Pharmaceuticals, Inc. (NYSE:AMRX)

AMRX

Corvus Pharmaceuticals Announces Publication Of Preclinical Data Demonstrating Potential Novel Approach To Immunotherapy Based On Inhibition Of ITK With Soquelitinib

By Happy Mohamed

July 6, 1:01 PM

Data highlights the differentiated mechanism of action of soquelitinib to enhance anti-tumor immune response to hematologic and solid tumors Soquelitinib shown to increase infiltration of cancer killing T cells

CRVS

Why DocuSign Stock Is Moving After Hours

By Adam Eckert

September 22, 5:04 PM

DocuSign Inc (NASDAQ: DOCU) shares are volatile in Thursday's after-hours session after the company announced that it had selected Allan Thygesen as its new Chief Executive.

DOCU